The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Gallium [Ga-68] (Brand name: Netspot)
- Manufactured by
Advanced Accelerator Applications, USA
FDA-approved indication: For use after radiolabeling with Ga 68, with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients.
National Library of Medicine Drug Information Portal